查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2081928

口蹄疫疫苗市場：2026-2032年全球市場預測（按疫苗類型、目標動物、給藥途徑、應用、分銷管道和最終用戶分類）

Foot & Mouth Disease Vaccines Market by Vaccine Type, Animal Type, Route Of Administration, Application, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，口蹄疫疫苗市場規模將達到 60.1 億美元，複合年成長率為 9.38%。

主要市場統計數據
基準年 2025 32.1億美元
預計年份：2026年 34.9億美元
預測年份 2032 60.1億美元
複合年成長率 (%) 9.38%

口蹄疫是一種高度傳染性的跨國動物疫病，可感染牛、豬、羊、山羊、水牛以及易感野生動物，因此口蹄疫疫苗仍是畜牧業生物安全的核心。根據世界動物衛生組織（WOAH）和聯合國糧食及農業組織（FAO）的指南，疫苗接種與監測、移動限制、快速診斷和強力的獸醫管理相結合，才能發揮最佳效果。

該市場受七種免疫學上不同的口蹄疫病毒血清型、區域株多樣性以及對抗原匹配疫苗的需求所影響。在地方性疾病風險、牛密度、出口保護和政府主導的免疫計畫相互交織的地區，需求最為旺盛，尤其是在畜牧業生產與糧食安全、農村生計和國際貿易密切相關的地區。

口蹄疫疫苗情勢的變革性變化

口蹄疫疫苗的格局正從疫情爆發後的被動應對策略轉向以預防主導的疾病控制策略。各國政府正努力擴大疫苗儲備，加強低溫運輸系統，並使國家計畫與世界動物衛生組織（WOAH）認證的口蹄疫控制指南保持一致，以保護肉類、乳製品和活畜的貿易。

人工智慧（AI）的累積影響

人工智慧（AI）透過整合基因組監測、疫情報告、牲畜流動數據、氣候相關風險指標和疫苗庫存信息，正在改進口蹄疫（FMD）疫苗接種的決策流程。人工智慧驅動的分析有助於識別流行株、確定抗原相容性的優先順序，並模擬在哪些地區進行緊急疫苗接種能夠最有效地控制疫情傳播。

按地區分類的主要見解

亞太地區是重要的需求中心。儘管中國、印度和東南亞部分地區面臨大規模的牲畜存欄量和持續存在的口蹄疫風險，但澳洲和日本透過邊境生物安全、監測和緊急應變系統，維持著嚴格的無口蹄疫計畫。北美地區基本上沒有口蹄疫，其重點在於提升應變能力、建立疫苗庫、改善診斷系統、加強監測和快速反應能力，以保障畜牧業生產和貿易的持續進行。

關鍵群體特定見解

東協市場的特點是跨境動物流動頻繁、畜牧養殖小規模，以及需要協調一致的疾病防控，尤其是在牛、水牛和豬的生產與非正式貿易路線交匯的地區。海灣合作理事會（GCC）國家重視進口管制、獸醫監督、檢疫系統和緊急疫苗供應，以降低動物和動物產品流動的感染風險。歐盟透過協調動物衛生法律、實驗室、診斷能力、可追溯性和緊急應變系統，制定了高標準的監管措施。

主要國家的概況

美國和加拿大仍致力於維持無口蹄疫狀態，確保疫苗庫的供應，發展診斷系統，進行模擬演練，並制定緊急應變計畫。同時，墨西哥透過邊境管制、監測和協調一致的動物衛生安全措施來維持無口蹄疫狀態。巴西在拉丁美洲的抗疫進展中發揮核心作用，這得益於數十年來協調一致的疫苗接種、監測政策、區域分類和以出口為導向的疾病控制管治。

為行業領導者提供的實用建議

行業領導者應優先考慮抗原相容性驗證、收集區域病毒株資訊以及與國家獸醫部門合作。投資於檢驗的多價疫苗、高效應急產品、安全的抗原儲備和可靠的低溫運輸系統，對於地方性疾病控制和疫情防治都至關重要。

調查方法

本調查方法建立在經過驗證的二手研究之上，包括世界動物衛生組織 (WOAH) 和聯合國糧農組織 (FAO) 的疾病控制指南、國家獸醫當局的出版刊物、同行評審的科學文獻、參考實驗室的最新資訊以及關於口蹄疫監測、檢驗、診斷和應急準備的公共政策文件。

結論

口蹄疫疫苗對於保護牲畜健康、糧食安全、農村經濟和國際牲畜貿易至關重要。其有效性取決於使用針對流行病毒株的疫苗、維持品質有保證的供應，以及將疫苗接種納入更廣泛的監測、診斷、移動限制和生物安全機制中。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：口蹄疫疫苗市場：依疫苗類型分類

  • 傳統疫苗
    • 去活化疫苗
    • 油性疫苗
    • 氫氧化鋁/皂素疫苗
  • 改良/減毒活病毒疫苗
  • 重組疫苗
  • 緊急疫苗

第8章：口蹄疫疫苗市場：依動物類型分類

  • 牛
  • 豬
  • 綿羊和山羊

第9章：口蹄疫疫苗市場：依給藥途徑分類

  • 注射
  • 口服

第10章：口蹄疫疫苗市場：依應用領域分類

  • 為了預防
  • 治療用途

第11章：口蹄疫疫苗市場：依通路分類

  • 離線
    • 百貨公司
    • 直銷
    • 專賣店
  • 線上
    • 每家公司的網站
    • 電子商務平台

第12章：口蹄疫疫苗市場：依最終用戶分類

  • 診所
  • 醫院
  • 研究機構

第13章：口蹄疫疫苗市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 口蹄疫疫苗市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 口蹄疫疫苗市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Agrovet Market Animal Health SA
  • Bayer AG
  • BIGVET Biotech Co., Ltd.
  • Biogenesis Bago SA
  • Biovet Private Limited
  • Boehringer Ingelheim International GmbH
  • Botswana Vaccine Institute
  • Brilliant Bio Pharma Limited
  • Cavet Bio Co., Ltd.
  • Ceva Sante Animale SA
  • China Animal Husbandry Industry Co., Ltd.
  • Godrej Agrovet Limited
  • Hester Biosciences Limited
  • Indian Immunologicals Limited
  • Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
  • Inovet BV
  • Intervac Pvt. Ltd.
  • Jinyu Bio-Technology Co., Ltd.
  • Limor de Colombia SA
  • Merck & Co., Inc.
  • Middle East Vaccines Company
  • Phibro Animal Health Corporation
  • Selevac Pty Ltd
  • Shen Lian Biotechnology Co., Ltd.
  • Tecon Biology Co., Ltd.
  • VECOL SA
  • VETAL Animal Health Products Inc.
  • Zoetis Inc.
Product Code: MRR-4316E4E8956A

The Foot & Mouth Disease Vaccines Market is projected to grow by USD 6.01 billion at a CAGR of 9.38% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.21 billion
Estimated Year [2026] USD 3.49 billion
Forecast Year [2032] USD 6.01 billion
CAGR (%) 9.38%

Foot and mouth disease vaccines remain central to livestock biosecurity because FMD is a highly contagious transboundary animal disease affecting cattle, pigs, sheep, goats, buffalo, and susceptible wildlife. According to WOAH and FAO guidance, vaccination is most effective when paired with surveillance, movement control, rapid diagnostics, and strong veterinary governance.

The market is shaped by seven immunologically distinct FMD virus serotypes, regional strain diversity, and the need for antigenically matched vaccines. Demand is strongest where endemic risk, cattle density, export protection, and government-led immunization programs converge, particularly in regions where livestock production is closely linked to food security, rural livelihoods, and access to international trade.

Transformative Shifts in the FMD Vaccine Landscape

The FMD vaccines landscape is shifting from reactive outbreak response toward prevention-led disease control. Governments are expanding vaccine banks, strengthening cold-chain readiness, and aligning national programs with WOAH-recognized FMD control pathways to protect meat, dairy, and live-animal trade.

Manufacturers are competing on high-potency formulations, purified inactivated vaccines, multivalent coverage, and validated quality systems. At the same time, DIVA-compatible strategies, improved diagnostics, and molecular epidemiology are making vaccine selection more evidence-driven and region-specific, helping veterinary authorities connect field surveillance with targeted vaccination policies.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is improving how FMD vaccine decisions are made by connecting genomic surveillance, outbreak reports, animal movement data, climate-linked risk indicators, and vaccine inventory signals. AI-supported analytics can help identify circulating lineages, prioritize antigen matching, and model where emergency vaccination would reduce spread most efficiently.

In manufacturing and distribution, AI can support batch consistency monitoring, demand planning, cold-chain risk detection, and procurement coordination. Its value depends on validated datasets, veterinary oversight, and responsible integration with laboratory-confirmed epidemiology rather than replacing expert judgment.

Key Regional Insights

Asia-Pacific represents a major demand center because China, India, and parts of Southeast Asia combine large livestock populations with persistent FMD risk, while Australia and Japan maintain strict freedom programs through border biosecurity, surveillance, and emergency preparedness. North America is largely FMD-free and focuses on preparedness, vaccine banks, diagnostic readiness, surveillance, and rapid response capacity to protect livestock production and trade continuity.

Latin America continues to advance FMD-free recognition and export protection, with Brazil playing a pivotal role in cattle-sector disease policy and progressive vaccination-to-surveillance transitions in recognized zones. Europe emphasizes non-routine vaccination, rapid detection, movement controls, and contingency planning under harmonized animal-health frameworks. The Middle East faces import-related and transboundary risk due to livestock movement and regional trade flows, while Africa remains strategically important because multiple FMD serotypes circulate across pastoral, smallholder, and cross-border livestock systems, making antigen matching and coordinated vaccination essential.

Key Group Insights

ASEAN markets are shaped by cross-border animal movement, smallholder livestock systems, and coordinated disease-control needs, especially where cattle, buffalo, and pig production intersect with informal trade routes. The GCC emphasizes import security, veterinary surveillance, quarantine capacity, and contingency access to vaccines to reduce exposure from animal and animal-product movements. The European Union sets a high regulatory benchmark through harmonized animal-health law, laboratory networks, diagnostic capacity, traceability, and emergency preparedness.

BRICS countries are influential because they include major livestock producers, large vaccination programs, expanding animal-health manufacturing capabilities, and significant exposure to food security and trade-protection priorities. G7 countries drive innovation, funding, reference-laboratory collaboration, and biosecurity standards, while NATO members increasingly treat animal disease preparedness as part of broader resilience for food supply chains, civil protection, and critical infrastructure continuity.

Key Country Insights

The United States and Canada remain focused on FMD freedom, vaccine-bank access, diagnostic readiness, simulation exercises, and emergency response planning, while Mexico maintains FMD-free status through border controls, surveillance, and coordinated animal-health safeguards. Brazil is central to Latin American progress, supported by decades of coordinated vaccination, surveillance policy, zoning, and export-oriented disease-control governance.

In Europe, the United Kingdom, Germany, France, Italy, and Spain rely on EU-aligned or comparable controls, rapid diagnostics, traceability, movement restrictions, and contingency vaccination rather than routine use. Russia manages risk across diverse livestock zones and long land borders. China and India sustain large-scale immunization needs due to livestock density and endemic exposure, Japan and Australia prioritize exclusion through strict biosecurity and emergency preparedness, and South Korea combines surveillance with vaccination informed by prior outbreak experience and intensive livestock production systems.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize antigen matching, regional strain intelligence, and partnerships with national veterinary authorities. Investment in validated multivalent vaccines, high-potency emergency products, secure antigen reserves, and reliable cold-chain systems will be critical for both endemic control and outbreak preparedness.

Organizations should also strengthen pharmacovigilance, DIVA-aligned testing support, field effectiveness monitoring, and transparent quality documentation. Commercial strategies should reflect public procurement cycles, export-market disease requirements, regulatory expectations, and the practical realities of vaccine delivery across smallholder, intensive, and transboundary livestock systems.

Research Methodology

Research methodology is built from verified secondary research, including WOAH and FAO disease-control guidance, national veterinary authority publications, peer-reviewed scientific literature, reference-laboratory updates, and publicly available policy documents on FMD surveillance, vaccination, diagnostics, and emergency preparedness.

The analysis emphasizes triangulation across epidemiology, regulatory frameworks, procurement behavior, livestock demographics, serotype and lineage circulation, vaccine technology trends, and trade-related animal-health requirements. Market interpretation excludes unsupported revenue claims and focuses on evidence-backed drivers such as disease status, vaccination policy, biosecurity readiness, antigenic matching, and trade-protection incentives.

Conclusion

Foot and mouth disease vaccines are essential tools for protecting livestock health, food security, rural economies, and international animal-product trade. Their effectiveness depends on matching vaccines to circulating strains, maintaining quality-assured supply, and embedding immunization within broader surveillance, diagnostics, movement control, and biosecurity systems.

The strongest opportunities will emerge for manufacturers and public-sector partners that combine scientific credibility, regional preparedness, digital intelligence, regulatory alignment, and dependable field execution. As FMD risk remains uneven across regions, the market will continue to reward evidence-based, adaptable, and policy-aligned vaccine strategies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Foot & Mouth Disease Vaccines Market, by Vaccine Type

  • 7.1. Conventional Vaccines
    • 7.1.1. Inactivated (Killed) Vaccines
    • 7.1.2. Oil-Based Vaccines
    • 7.1.3. Aluminum Hydroxide/Saponin-Based Vaccines
  • 7.2. Modified / Attenuated Live Vaccines
  • 7.3. Recombinant Vaccines
  • 7.4. Emergency Vaccines

8. Foot & Mouth Disease Vaccines Market, by Animal Type

  • 8.1. Cattle
  • 8.2. Swine
  • 8.3. Sheep & goats

9. Foot & Mouth Disease Vaccines Market, by Route Of Administration

  • 9.1. Injection
  • 9.2. Oral

10. Foot & Mouth Disease Vaccines Market, by Application

  • 10.1. Preventive
  • 10.2. Therapeutic

11. Foot & Mouth Disease Vaccines Market, by Distribution Channel

  • 11.1. Offline
    • 11.1.1. Department Stores
    • 11.1.2. Direct Sales
    • 11.1.3. Specialty Stores
  • 11.2. Online
    • 11.2.1. Company Websites
    • 11.2.2. E-commerce Platforms

12. Foot & Mouth Disease Vaccines Market, by End User

  • 12.1. Clinics
  • 12.2. Hospitals
  • 12.3. Research Institutes

13. Foot & Mouth Disease Vaccines Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Foot & Mouth Disease Vaccines Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Foot & Mouth Disease Vaccines Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Agrovet Market Animal Health S.A.
  • 17.2. Bayer AG
  • 17.3. BIGVET Biotech Co., Ltd.
  • 17.4. Biogenesis Bago S.A.
  • 17.5. Biovet Private Limited
  • 17.6. Boehringer Ingelheim International GmbH
  • 17.7. Botswana Vaccine Institute
  • 17.8. Brilliant Bio Pharma Limited
  • 17.9. Cavet Bio Co., Ltd.
  • 17.10. Ceva Sante Animale S.A.
  • 17.11. China Animal Husbandry Industry Co., Ltd.
  • 17.12. Godrej Agrovet Limited
  • 17.13. Hester Biosciences Limited
  • 17.14. Indian Immunologicals Limited
  • 17.15. Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
  • 17.16. Inovet BV
  • 17.17. Intervac Pvt. Ltd.
  • 17.18. Jinyu Bio-Technology Co., Ltd.
  • 17.19. Limor de Colombia S.A.
  • 17.20. Merck & Co., Inc.
  • 17.21. Middle East Vaccines Company
  • 17.22. Phibro Animal Health Corporation
  • 17.23. Selevac Pty Ltd
  • 17.24. Shen Lian Biotechnology Co., Ltd.
  • 17.25. Tecon Biology Co., Ltd.
  • 17.26. VECOL S.A.
  • 17.27. VETAL Animal Health Products Inc.
  • 17.28. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONVENTIONAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONVENTIONAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONVENTIONAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INACTIVATED (KILLED) VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INACTIVATED (KILLED) VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INACTIVATED (KILLED) VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL OIL-BASED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL OIL-BASED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL OIL-BASED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ALUMINUM HYDROXIDE/SAPONIN-BASED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ALUMINUM HYDROXIDE/SAPONIN-BASED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ALUMINUM HYDROXIDE/SAPONIN-BASED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MODIFIED / ATTENUATED LIVE VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MODIFIED / ATTENUATED LIVE VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MODIFIED / ATTENUATED LIVE VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL EMERGENCY VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL EMERGENCY VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL EMERGENCY VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SHEEP & GOATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SHEEP & GOATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SHEEP & GOATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INJECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INJECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INJECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PREVENTIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PREVENTIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PREVENTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL THERAPEUTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL THERAPEUTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL THERAPEUTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DEPARTMENT STORES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DEPARTMENT STORES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DEPARTMENT STORES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SPECIALTY STORES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SPECIALTY STORES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SPECIALTY STORES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL COMPANY WEBSITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL COMPANY WEBSITES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL COMPANY WEBSITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL E-COMMERCE PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL E-COMMERCE PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL E-COMMERCE PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GCC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 153. GCC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. GCC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 155. GCC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. GCC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 157. GCC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. GCC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. GCC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 160. GCC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 161. GCC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. G7 FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. G7 FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. G7 FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 185. G7 FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. G7 FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 187. G7 FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. G7 FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. G7 FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 190. G7 FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 191. G7 FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. NATO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. NATO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. NATO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 195. NATO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. NATO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 197. NATO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. NATO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. NATO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 200. NATO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 201. NATO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 214. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 216. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 218. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 221. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 222. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 226. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 228. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 231. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 232. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 236. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 238. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 241. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 242. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 256. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 258. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 261. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 262. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 266. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 268. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 271. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 272. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 276. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 278. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 280. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 281. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 282. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 286. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 288. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 290. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 291. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 292. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 293. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 296. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 298. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 299. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 301. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 302. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 306. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 308. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 310. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 311. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 312. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 316. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 317. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 318. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 319. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 320. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 321. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 322. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 323. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL VACCINES, 2018-2032 (USD MILLION)
  • TABLE 326. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 328. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 329. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 330. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 331. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 332. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 333. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 334. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONV